Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Microbix Biosystems Inc
T.MBX
Alternate Symbol(s):
MBXBF
Healthcare
Biotechnology
Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency...
testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:MBX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(96)
•••
wizzdumb
X
View Profile
View Bullboard History
Comment by
wizzdumb
on Feb 14, 2024 12:46pm
RE:RE:New Press Release - Microbix Reports Record Results for Q1 Fiscal 2024
They addressed that also, significant investments have been made and continue to provide for capability to meet stated revenue goal of $50M. The entire Kinlytic business plan is for royalties
...more
(2139)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 14, 2024 12:38pm
RE:New Press Release - Microbix Reports Record Results for Q1 Fiscal 2024
If you exclude the Kinlytic and DTM revenues (Mar21 to June22) this co. makes little profit. Mgmt needs to get on with it. Qtr ending
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(96)
•••
wizzdumb
X
View Profile
View Bullboard History
Comment by
wizzdumb
on Feb 14, 2024 12:31pm
RE:RE:RE:RE:New Press Release - Microbix Reports Record Results for Q1 Fiscal 2024
You should really listen to the call. Will be record year w/o the Kinlytic royalties was clearly stated, aka core business.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Feb 14, 2024 12:30pm
RE:RE:New Press Release - Microbix Reports Record Results for Q1 Fiscal 2024
I think they want to sell their options into this...
(2139)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 14, 2024 12:21pm
RE:RE:RE:New Press Release - Microbix Reports Record Results for Q1 Fiscal 2024
Mgmt need to get base business growing... Qtr ending Antigen QAP DxTM Royalties/Licensing
...more
(2139)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 14, 2024 12:16pm
RE:RE:New Press Release - Microbix Reports Record Results for Q1 Fiscal 2024
Qtr ending G&A expense Dec 23 2,804,716 Sep 23 1,485,588
...more
(2139)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Feb 14, 2024 12:04pm
RE:New Press Release - Microbix Reports Record Results for Q1 Fiscal 2024
The bozos should have disclosed how much was the one-time consulting fee expense for Kinlytic so that people backing out the one-time Kinlytic revenues could get a true net income....
...more
(10)
•••
ssdasmm
X
View Profile
View Bullboard History
Comment by
ssdasmm
on Feb 14, 2024 11:39am
RE:RE:Whoa…….
you heard right
(10)
•••
RICHOFFMBX
X
View Profile
View Bullboard History
Comment by
RICHOFFMBX
on Feb 14, 2024 10:39am
RE:Whoa…….
I'm multi-tasking at work... did I hear correctly? Cameron said he bought 3 million shares?
(10)
•••
RICHOFFMBX
X
View Profile
View Bullboard History
Comment by
RICHOFFMBX
on Feb 14, 2024 9:51am
RE:Whoa…….
Over 200K volume out the gates! Nice start.
(10)
•••
RICHOFFMBX
X
View Profile
View Bullboard History
Comment by
RICHOFFMBX
on Feb 14, 2024 8:00am
RE:Whoa…….
Congrats to the MBX longs! This is just the beginning...
(96)
•••
wizzdumb
X
View Profile
View Bullboard History
Comment by
wizzdumb
on Feb 14, 2024 7:36am
RE:Whoa…….
Sweet, just wait until royalty revenues are $15-25M US per year in a couple of years. I actually expected QAPs numbers to be higher, which means Q2 will be extremely strong. Antigens are back and
...more
(67)
•••
rjc7
X
View Profile
View Bullboard History
Post by
rjc7
on Feb 14, 2024 7:25am
Whoa…….
Happy Valentine Day to all. We're finally off and running $$$$$$$
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Feb 14, 2024 7:14am
New Press Release - Microbix Reports Record Results for Q1 Fiscal 2024
Record Revenues of $8.4 million and Record Net Income of $2.5 million MISSISSAUGA, Ontario, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its first quarter of fiscal 2024...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >